These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 8090335
1. Influence of diltiazem on renal function and rejection in renal allograft recipients receiving triple-drug immunosuppression: a randomized, double-blind, placebo-controlled study. Ladefoged SD, Pedersen E, Hammer M, Rasmussen KC, Hansen FM, Andersen CB. Nephrol Dial Transplant; 1994; 9(5):543-7. PubMed ID: 8090335 [Abstract] [Full Text] [Related]
2. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols. Suthanthiran M, Haschemeyer RH, Riggio RR, Adubor C, Friedman GS, Cheigh JS, Wang JC, Fotino M, Stubenbord WT, Saal SD. Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873 [Abstract] [Full Text] [Related]
3. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation]. Zhu L, Ding T, Wang XX, Lin ZB, Chen G. Zhonghua Yi Xue Za Zhi; 2016 May 31; 96(20):1556-61. PubMed ID: 27266681 [Abstract] [Full Text] [Related]
4. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Grinyó JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado JM, Moreso F, Fernandez A, Torras J, Riera L, Castelao AM, Alsina J. Nephrol Dial Transplant; 1998 Oct 31; 13(10):2601-4. PubMed ID: 9794567 [Abstract] [Full Text] [Related]
5. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers. Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A. Isr Med Assoc J; 2002 Nov 31; 4(11 Suppl):935-9. PubMed ID: 12455184 [Abstract] [Full Text] [Related]
6. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients. Kasiske BL, Johnson HJ, Goerdt PJ, Heim-Duthoy KL, Rao VK, Dahl DC, Ney AL, Andersen RC, Jacobs DM, Odland MD. Am J Kidney Dis; 1997 Nov 31; 30(5):639-45. PubMed ID: 9370178 [Abstract] [Full Text] [Related]
8. Delayed graft function of cadaveric renal transplants is prevented by diltiazem. Carmellini M, Salvadori M, Di Stefano R, Bertoni E, Nicita G, Rosati A, Taddei G, Rindi P, Rizzo G, Mosca F. Transplant Proc; 1996 Feb 31; 28(1):80-2. PubMed ID: 8644348 [No Abstract] [Full Text] [Related]
9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW. Clin Transplant; 1997 Aug 31; 11(4):299-312. PubMed ID: 9267719 [Abstract] [Full Text] [Related]
10. Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients. Kandus A, Grego K, Bren AF. Ther Apher Dial; 2005 Jun 31; 9(3):262-4. PubMed ID: 15967003 [Abstract] [Full Text] [Related]
11. Protective effects of diltiazem and the prostazycline analogue iloprost in human renal transplantation. Neumayer HH, Kunzendorf U, Schreiber M. Ren Fail; 1992 Jun 31; 14(3):289-96. PubMed ID: 1380721 [Abstract] [Full Text] [Related]
12. Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation. Valantine H, Keogh A, McIntosh N, Hunt S, Oyer P, Schroeder J. J Heart Lung Transplant; 1992 Jun 31; 11(1 Pt 1):1-7; discussion 7-8. PubMed ID: 1540597 [Abstract] [Full Text] [Related]
13. Effect of early cyclosporine levels on kidney allograft rejection. Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ. Clin Transplant; 1997 Dec 31; 11(6):552-7. PubMed ID: 9408683 [Abstract] [Full Text] [Related]
14. Effect of nifedipine on renal allograft function and survival beyond one year. Shin GT, Cheigh JS, Riggio RR, Suthanthiran M, Stubenbord WT, Serur D, Wang JC, Rubin AL, Stenzel KH. Clin Nephrol; 1997 Jan 31; 47(1):33-6. PubMed ID: 9021239 [Abstract] [Full Text] [Related]
15. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC. Transpl Immunol; 2008 Nov 31; 20(1-2):32-42. PubMed ID: 18773960 [Abstract] [Full Text] [Related]
16. Dietary fish oil in renal transplant recipients treated with cyclosporin-A: no beneficial effects shown. Kooijmans-Coutinho MF, Rischen-Vos J, Hermans J, Arndt JW, van der Woude FJ. J Am Soc Nephrol; 1996 Mar 31; 7(3):513-8. PubMed ID: 8704119 [Abstract] [Full Text] [Related]
17. Protective effects of calcium antagonists in human renal transplantation. Neumayer HH, Kunzendorf U, Schreiber M. Kidney Int Suppl; 1992 May 31; 36():S87-93. PubMed ID: 1377295 [Abstract] [Full Text] [Related]